(19)
(11) EP 1 140 022 A2

(12)

(88) Date of publication A3:
12.10.2000

(43) Date of publication:
10.10.2001 Bulletin 2001/41

(21) Application number: 99963103.9

(22) Date of filing: 17.12.1999
(51) International Patent Classification (IPC)7: A61K 9/127, A61K 31/704, A61K 31/137, A61K 47/48, A61P 35/00
(86) International application number:
PCT/US9930/230
(87) International publication number:
WO 0035/422 (22.06.2000 Gazette 2000/25)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.12.1998 US 113004 P

(71) Applicants:
  • HADASIT MEDICAL RESEARCH SERVICES &DEVELOPMENT COMPANY, LTD.
    91120 Jerusalem (IL)
  • Alza Corporation
    Mountain View, CA 94039-7210 (US)

(72) Inventors:
  • GABIZON, Alberto, A.
    96920 Jerusalem (IL)
  • ZALIPSKY, Samuel
    Redwood City, CA 94061 (US)
  • GOREN-RUBEL, Dorit
    93389 Jerusalem (IL)
  • HOROWITZ, Aviva, T.
    92548 Jerusalem (IL)

(74) Representative: Suèr, Steven Johannes et al
Ablett & Stebbing,Caparo House,101-103 Baker Street
London W1M 1FD
London W1M 1FD (GB)

   


(54) METHOD OF ADMINISTERING A COMPOUND TO MULTI-DRUG RESISTANT CELLS